Optimization and Validation of a Cheaper, Safer, and More Sustainable Methodology for Aflatoxins Determination in Rich-Lipidic Matrices (Pistachio Nuts) Using Deep Eutectic Solvent Extraction and UHPLC-FLD Analysis.
Andrea SchincagliaLuisa PastiAlberto CavazziniGiorgia PurcaroMarco BeccariaPublished in: Journal of agricultural and food chemistry (2024)
Aflatoxins pose a major health concern and require strict monitoring in food products. Existing methods rely on hazardous organic solvents for extraction, prompting the development of a greener alternative. This study explores deep eutectic solvents (DESs) for aflatoxin extraction from pistachios, a valuable food product prone to aflatoxin contamination. The proposed method utilizes DES extraction followed by solid-phase extraction cleanup and ultrahigh-performance liquid chromatography coupled with fluorescence detector analysis. Recovery rates ranged from 85.5 to 99.1% for pistachios spiked with 1-8 ng/g aflatoxins, in compliance with EU regulations, with coefficients of variation less than 2.94%. The method demonstrates good sensitivity with limits of detection and quantification in the range of 0.02-0.22 ng/g and 0.05-0.72 ng/g, respectively. Greenness assessment using AGREEPrep and White Analytical Chemistry metrics confirms its environmental sustainability. This approach offers a promising, safer, and more eco-friendly alternative for aflatoxin extraction from complex food matrices like pistachios.
Keyphrases
- solid phase extraction
- liquid chromatography
- tandem mass spectrometry
- human health
- high performance liquid chromatography
- molecularly imprinted
- simultaneous determination
- liquid chromatography tandem mass spectrometry
- mass spectrometry
- high resolution mass spectrometry
- ultra high performance liquid chromatography
- gas chromatography mass spectrometry
- risk assessment
- ionic liquid
- healthcare
- magnetic resonance imaging
- ms ms
- gas chromatography
- public health
- quantum dots
- climate change
- health information
- heavy metals
- low cost
- drug discovery